DGKA

Across TCGA pan-cancer cohorts, DGKA mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated DGKA data layer compared with 23 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher DGKA mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated DGKA expression acts as an unfavorable survival marker, although some lineages such as PDAC and HNSC show a favorable association.

PDAC, UCEC, and HNSC are the cancer types where DGKA mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Quartile	II,III,IV	0.481	0.218	.035	7	view →
UCEC	DFS	Median	II,III,IV	0.826	1.000	.047	2	view →
HNSC	DFS	Quartile	II,III,IV	1.000	0.899	.042	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

DGKA–PDAC (OS)

Open the PDAC breakdown →